Last updated 2026-08-19
- Raised $7M Series A led by Denali Ventures, 1999
- Raised $2M Series B led by Medica Venture Partners
Total raised
$9.0M
Stage
—
Founded
1996
Headcount
—
HQ
Petach Tikva, Israel
Sector
Pharmaceuticals
Registrar ID: 512197740 (Collgard Biopharmaceuticals Ltd.)
About
Collgard Biopharmaceuticals develops unique therapeutic products that affect the turnover of collagen to prevent or treat scleroderma, solid tumors, restenosis, and other fibrotic disorders. The company focuses on developing drug treatments that directly impact the tissue regeneration process to target disease progression. Their versatile lead compound is halofuginone, which appears to specifically block the production of collagen type 1.
Funding history · 2 rounds · $9.0M total
2 events/rounds · $9.0M Total Funding: $9.0M in Private Equity
1999
Date unknown
B Round
$2.0M
tracxn.com
Offices
Petach Tikva, Israel · HQ / main office
Q&A
- What is Collgard Biopharmaceuticals Ltd.'s primary business?
- Collgard Biopharmaceuticals Ltd. develops unique therapeutic products that affect the turnover of collagen to prevent or treat scleroderma, solid tumors, restenosis, and other fibrotic disorders. Their focus is on drug treatments that directly impact the tissue regeneration process.
- When was Collgard Biopharmaceuticals Ltd. founded?
- Collgard Biopharmaceuticals Ltd. was founded in 1996.
- What is the current status of Collgard Biopharmaceuticals Ltd.?
- Collgard Biopharmaceuticals Ltd. was acquired in March 2011.
- What is Collgard Biopharmaceuticals Ltd.'s primary sector?
- Collgard Biopharmaceuticals Ltd.'s primary sector is Pharmaceuticals.
- What is the total amount of funding raised by Collgard Biopharmaceuticals Ltd.?
- Collgard Biopharmaceuticals Ltd. raised a total of $18,000,000 across all funding rounds.
- Which investors participated in Collgard Biopharmaceuticals Ltd.'s A Round funding?
- Collgard Biopharmaceuticals Ltd.'s A Round funding included investments from Denali Ventures.
- When did Collgard Biopharmaceuticals Ltd. raise its B Round funding?
- Collgard Biopharmaceuticals Ltd. raised $2,000,000 in its B Round funding in 1997.
- What is the lead compound developed by Collgard Biopharmaceuticals Ltd.?
- Collgard Biopharmaceuticals Ltd.'s versatile lead compound is halofuginone, which appears to specifically block the production of collagen type 1.
Team · 1
Neal Farber
President, Chief Executive Officer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1996 |
|---|
Acquisitions & public offerings
Acquired by 2011-03
Radar intelligence
Patents
| EPO | 6 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512197740 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1995-08-30 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | מדינת היהודים 60 הרצליה |